Agnes Shanley, Editor || July 16, 2014 Are the tax savings from inversions worth the damage to corporate identity and culture? Can you even identify individual pharma company missions and corporate cultures anymore?
Agnes Shanley, Editor || May 1, 2014 Do we need to get more sophisticated about the way we view data, but more primitive in the way that we communicate with peers and contract partners? Is more “face time” needed?
Gil Roth, Editor || January 24, 2014 Last issue, I promised a new design for the magazine, and I delivered! (Courtesy of the expert work of our art department, especially Mike Del Purgatorio and Jessica Carlin!)
Our readers and advertisers are concerned about deliverables of much highe…